Lista de obras - Diego García-Borreguero

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

artículo científico publicado en 2007

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome

artículo científico publicado en 2010

A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions

artículo científico

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

artículo científico publicado en 2011

Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

artículo científico

An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment

artículo científico

Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials

artículo científico publicado en 2007

Augmentation as a treatment complication of restless legs syndrome: concept and management

artículo científico publicado en 2007

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine

artículo científico publicado en 2012

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment

artículo científico

Augmentation: understanding a key feature of RLS.

artículo científico publicado en 2004

Catalogue of knowledge and skills for sleep medicine.

artículo científico publicado en 2013

Circadian effects of dopaminergic treatment in restless legs syndrome

artículo científico publicado en 2004

Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG).

artículo científico publicado en 2007

Comparison of pregabalin with pramipexole for restless legs syndrome

artículo científico publicado en 2014

Correlation between rating scales and sleep laboratory measurements in restless legs syndrome.

artículo científico publicado en 2004

Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness

artículo científico publicado en 2002

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

artículo científico publicado en 2007

Did Immanuel Kant have dementia with Lewy bodies and REM behavior disorder?

artículo científico publicado en 2010

Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management

artículo científico

Dopaminergic augmentation of restless legs syndrome

artículo científico publicado en 2010

Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study

artículo científico publicado en 2007

Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome

artículo científico publicado en 2015

Epidemiology of restless legs syndrome: the current status.

artículo científico publicado en 2006

European guidelines for the certification of professionals in sleep medicine: report of the task force of the European Sleep Research Society

scientific article published on March 2009

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

artículo científico publicado en 2012

Fluctuations in cognition and alertness in Parkinson's disease and dementia

artículo científico publicado en 2004

In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine

artículo científico publicado en 2016

New concepts in the management of restless legs syndrome

artículo científico publicado en 2017

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

artículo científico publicado en 2008

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome

artículo científico publicado en 2014

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

artículo científico publicado en 2009

Restless legs syndrome and PD: a review of the evidence for a possible association

artículo científico publicado en 2003

Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance

artículo científico

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study

artículo científico publicado en 2010

Sodium oxybate is an effective and safe treatment for narcolepsy

artículo científico publicado en 2009

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

artículo científico publicado en 2013

The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Stud

artículo científico publicado en 2006

Thomas de Quincey and his restless legs symptoms as depicted in “Confessions of an English Opium‐Eater” ⬇️

artículo científico publicado el 15 de octubre de 2010

Time to REST: epidemiology and burden

artículo científico publicado en 2006

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

artículo científico publicado en 2010

Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel

artículo científico

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

artículo científico publicado en 2007

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)

artículo científico publicado en 2013

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome

artículo científico

Lista de obras de Diego García-Borreguero

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome

A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment

Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials

Augmentation as a treatment complication of restless legs syndrome: concept and management

Augmentation in the treatment of restless legs syndrome with transdermal rotigotine

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment

Augmentation: understanding a key feature of RLS.

Catalogue of knowledge and skills for sleep medicine.

Circadian effects of dopaminergic treatment in restless legs syndrome

Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG).

Comparison of pregabalin with pramipexole for restless legs syndrome

Correlation between rating scales and sleep laboratory measurements in restless legs syndrome.

Decreased phasic EMG activity during rapid eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

Did Immanuel Kant have dementia with Lewy bodies and REM behavior disorder?

Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management

Dopaminergic augmentation of restless legs syndrome

Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study

Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome

Epidemiology of restless legs syndrome: the current status.

European guidelines for the certification of professionals in sleep medicine: report of the task force of the European Sleep Research Society

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

Fluctuations in cognition and alertness in Parkinson's disease and dementia

In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine

New concepts in the management of restless legs syndrome

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

Restless legs syndrome and PD: a review of the evidence for a possible association

Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance

Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study

Sodium oxybate is an effective and safe treatment for narcolepsy

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Stud

Thomas de Quincey and his restless legs symptoms as depicted in “Confessions of an English Opium‐Eater” ⬇️

Time to REST: epidemiology and burden

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome